GGrantIndex
← Search

Tissue Acquisition

$176,010P30FY2011CANIH

University Of Arizona, Tucson AZ

Investigators

Linked publications, trials & patents

Paper 39631050Paper 39622842Paper 39612086Paper 39361227Paper 39312766Paper 39151774Paper 39100646Paper 39075233Paper 38875929Paper 38858600Paper 38826434Paper 38804255Paper 38769192Paper 38759377Paper 38729260Paper 38719743Paper 38715255Paper 38687603Paper 38658768Paper 38639990Paper 38613866Paper 38612480Paper 38474232Paper 38464045Paper 38453918Paper 38386696Paper 38386396Paper 38328594Paper 38313301Paper 38309054Paper 38291312Paper 38215755Paper 38203706Paper 38199366Paper 38164625Paper 38164604Paper 38097734Paper 38097593Paper 38096366Trial NCT07214506Trial NCT06009926Trial NCT05699603Trial NCT05237960Trial NCT05121051Trial NCT04530552Trial NCT03708055Trial NCT03602066Trial NCT03601507Trial NCT03578432Trial NCT03422536Trial NCT03402230Trial NCT03376971Trial NCT03365895Trial NCT03196180Trial NCT02581137Trial NCT02568566Trial NCT02348203Trial NCT02326805Trial NCT02123849Trial NCT01686165Trial NCT01433913Trial NCT01394211Trial NCT01385280Trial NCT01370889Trial NCT01288261Trial NCT01172028Trial NCT01097304Trial NCT01077453Trial NCT00980395Trial NCT00978718Trial NCT00900432Trial NCT00900341Trial NCT00898703Trial NCT00896935Trial NCT00892268Trial NCT00841204Trial NCT00752739Trial NCT00732498Trial NCT00721877Trial NCT00702299Trial NCT00701857Trial NCT00699907Trial NCT00619060Trial NCT00608634Trial NCT00601640Trial NCT00410618Trial NCT00373022Trial NCT00363805Trial NCT00303823Trial NCT00245024Trial NCT00091325Trial NCT00078897Trial NCT00003307Trial NCT00003082Patent 9486545Patent 9435812Patent 9415110Patent 9262824Patent 5650489Patent 5510240

Abstract

9.1.11 TISSUE ACQUISITION AND CELLULAR/MOLECULAR SHARED SERVICE The Tissue Acquistion and Cellular/Molecular Analysis Shared Service (TACMASS) performs two main functions for the Arizona Cancer Center (AZCC): 1. Tissue Acquisition: TACMASS cpilects, preserves, and banks biospecimens obtained from consented AZCC surgical patients. Banked bibspeciniens (frozen and formalin fixed, paraffin embedded tissues, genomic DNA, plasma, serum and urine) are annotated with clinical and pathological infomiation, which enables investigators to query a database to identify appropriate biospecimens that may be useful for analysis under University of Arizona Institutional Review Board (IRB) approved protocols. The overall goal is to provide cancer researchers with access to a repository of high quality, carefully collected and annotated human tumor tissue and body fluids for current and future translational studies in cancer. 2. Molecular and pathological analysis of tissues and cells: TACMASS provides AZCC researchers with access to state of the art molecular analytical tools using techniques of routine histology, immunohistochemistry. Laser Capture Microdissection, and the construction of Tissue Microarrays. TACMASS assists researchers with experimental design and the establishment of histological scoring strategies, and consults with investigators to analyze and interpret pathological findings in the overall context of the whole project. One ofthe primary goals of TACMASS is to provide AZCC researchers from all five programs with high quality pathological analysis and interpretation of experimental data. The Service is directed by Ray Nagle, M.D., Ph.D. Co-Directors are Achyut Bhattacharyya M.D. and Wenxin Zheng, M.D. The service is staffed with four research specialists.

View original record on NIH RePORTER →